Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2018

06.03.2018 | Original Article

Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?

verfasst von: Hai-Jie Hu, Yan-Wen Jin, Rong-Xing Zhou, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Fei Liu, Nan-Sheng Cheng, Fu-Yu Li

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of the study is to examine the feasibility of hepatic artery resection (HAR) without subsequent reconstruction (RCS) in specified patients of Bismuth type III and IV hilar cholangiocarcinoma.

Methods

We retrospectively reviewed 63 patients who underwent hepatic artery resection for Bismuth type III and IV hilar cholangiocarcinoma. These patients were subsequently enrolled into two groups based on whether the artery reconstruction was conducted. Postoperative morbidity and mortality, and long-term survival outcome were compared between the two groups.

Results

There were 29 patients in HAR group and 34 patients in the HAR + RCS group. Patients with hepatic artery reconstruction tended to have longer operative time (545.6 ± 143.1 min vs. 656.3 ± 192.8 min; P = 0.013) and smaller tumor size (3.0 ± 1.1 cm vs. 2.5 ± 0.9 cm; P = 0.036). The R0 resection margin was comparable between the HAR group and HAR + RCS group (86.2 vs. 85.3%; P > 0.05). Twelve patients (41.4%) with 24 complications in HAR group and 13 patients (38.2%) with 25 complications in HAR + RCS group were recorded (P = 0.799). The postoperative hepatic failure rate (13.8 vs. 5.9%) and postoperative mortality rate (3.4% vs. 2.9%) were also comparable between the two groups. In the HAR group, the overall 1-, 3-, and 5-year survival rates were 72, 41, and 19%, respectively; while in the HAR + RCS group, the overall 1-, 3-, and 5-year survival rates were 79, 45, and 25%, respectively (P = 0.928).

Conclusions

Hepatic artery resection without reconstruction is also a safe and feasible surgical procedure for highly selected cases of Bismuth type III and IV hilar cholangiocarcinoma.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C et al. Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study. Hepato-gastroenterology. 2010;57(104):1341–6.PubMed Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C et al. Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study. Hepato-gastroenterology. 2010;57(104):1341–6.PubMed
4.
Zurück zum Zitat Gerhards MF, van Gulik TM, Bosma A, ten Hoopen-Neumann H, Verbeek PC, Gonzalez Gonzalez D et al. Long-term survival after resection of proximal bile duct carcinoma (Klatskin tumors). World journal of surgery. 1999;23(1):91–6.CrossRefPubMed Gerhards MF, van Gulik TM, Bosma A, ten Hoopen-Neumann H, Verbeek PC, Gonzalez Gonzalez D et al. Long-term survival after resection of proximal bile duct carcinoma (Klatskin tumors). World journal of surgery. 1999;23(1):91–6.CrossRefPubMed
5.
Zurück zum Zitat Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232(2):166–74.CrossRefPubMedPubMedCentral Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232(2):166–74.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hu HJ, Shrestha A, Mao H, Li FY, Tan YQ, Ma WJ et al. Impact of different tumor size cut-off points on survival outcome after curative resection of hilar cholangiocarcinoma. International journal of clinical and experimental medicine. 2016;9(3):6178–89. Hu HJ, Shrestha A, Mao H, Li FY, Tan YQ, Ma WJ et al. Impact of different tumor size cut-off points on survival outcome after curative resection of hilar cholangiocarcinoma. International journal of clinical and experimental medicine. 2016;9(3):6178–89.
11.
Zurück zum Zitat Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C et al. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012;38(12):1197–203. https://doi.org/10.1016/j.ejso.2012.08.009.CrossRef Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C et al. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012;38(12):1197–203. https://​doi.​org/​10.​1016/​j.​ejso.​2012.​08.​009.CrossRef
13.
Zurück zum Zitat Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K et al. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Annals of surgical oncology. 2016;23(Suppl 4):475–84. https://doi.org/10.1245/s10434-016-5381-2.CrossRefPubMed Matsuyama R, Mori R, Ota Y, Homma Y, Kumamoto T, Takeda K et al. Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: With Special Reference to Hepatic Arterial Resection and Reconstruction. Annals of surgical oncology. 2016;23(Suppl 4):475–84. https://​doi.​org/​10.​1245/​s10434-016-5381-2.CrossRefPubMed
14.
Zurück zum Zitat Wu XS, Dong P, Gu J, Li ML, Wu WG, Lu JH et al. Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2013;17(6):1107–15. https://doi.org/10.1007/s11605-013-2202-9.CrossRef Wu XS, Dong P, Gu J, Li ML, Wu WG, Lu JH et al. Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2013;17(6):1107–15. https://​doi.​org/​10.​1007/​s11605-013-2202-9.CrossRef
16.
Zurück zum Zitat Noji T, Tsuchikawa T, Okamura K, Nakamura T, Tamoto E, Shichinohe T et al. Resection and reconstruction of the hepatic artery for advanced perihilar cholangiocarcinoma: result of arterioportal shunting. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2015;19(4):675–81. https://doi.org/10.1007/s11605-015-2754-y.CrossRef Noji T, Tsuchikawa T, Okamura K, Nakamura T, Tamoto E, Shichinohe T et al. Resection and reconstruction of the hepatic artery for advanced perihilar cholangiocarcinoma: result of arterioportal shunting. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2015;19(4):675–81. https://​doi.​org/​10.​1007/​s11605-015-2754-y.CrossRef
29.
Zurück zum Zitat de Santibanes E, Ardiles V, Alvarez FA, Pekolj J, Brandi C, Beskow A. Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2012;14(1):67–70. https://doi.org/10.1111/j.1477-2574.2011.00404.x.CrossRef de Santibanes E, Ardiles V, Alvarez FA, Pekolj J, Brandi C, Beskow A. Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2012;14(1):67–70. https://​doi.​org/​10.​1111/​j.​1477-2574.​2011.​00404.​x.CrossRef
31.
Zurück zum Zitat Boleslawski E, Bouras AF, Truant S, Liddo G, Herrero A, Badic B et al. Hepatic artery ligation for arterial rupture following liver transplantation: a reasonable option. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013;13(4):1055–62. https://doi.org/10.1111/ajt.12135.CrossRef Boleslawski E, Bouras AF, Truant S, Liddo G, Herrero A, Badic B et al. Hepatic artery ligation for arterial rupture following liver transplantation: a reasonable option. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013;13(4):1055–62. https://​doi.​org/​10.​1111/​ajt.​12135.CrossRef
32.
Zurück zum Zitat Pearce W, Dunn EL, Moore EE. Hepatic artery ligation for delayed hepatic hemorrhage. Archives of surgery. 1980;115(1):92.CrossRefPubMed Pearce W, Dunn EL, Moore EE. Hepatic artery ligation for delayed hepatic hemorrhage. Archives of surgery. 1980;115(1):92.CrossRefPubMed
34.
Zurück zum Zitat Lewis FR, Lim RC Jr., Blaisdell FW. Hepatic artery ligation: adjunct in the management of massive hemorrhage from the liver. Journal of Trauma. 1974;14(9):743–55.CrossRefPubMed Lewis FR, Lim RC Jr., Blaisdell FW. Hepatic artery ligation: adjunct in the management of massive hemorrhage from the liver. Journal of Trauma. 1974;14(9):743–55.CrossRefPubMed
38.
Zurück zum Zitat Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008;34(7):787–94. https://doi.org/10.1016/j.ejso.2007.10.005.CrossRef Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008;34(7):787–94. https://​doi.​org/​10.​1016/​j.​ejso.​2007.​10.​005.CrossRef
40.
Zurück zum Zitat Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507–17; discussion 17-9.CrossRefPubMedPubMedCentral Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507–17; discussion 17-9.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2002;6(4):617–24.CrossRef Kawarada Y, Das BC, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2002;6(4):617–24.CrossRef
43.
Zurück zum Zitat Noji T, Tsuchikawa T, Okamura K, Tanaka K, Nakanishi Y, Asano T et al. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching. Journal of hepato-biliary-pancreatic sciences. 2016;23(7):442–8. https://doi.org/10.1002/jhbp.363.CrossRefPubMed Noji T, Tsuchikawa T, Okamura K, Tanaka K, Nakanishi Y, Asano T et al. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching. Journal of hepato-biliary-pancreatic sciences. 2016;23(7):442–8. https://​doi.​org/​10.​1002/​jhbp.​363.CrossRefPubMed
Metadaten
Titel
Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?
verfasst von
Hai-Jie Hu
Yan-Wen Jin
Rong-Xing Zhou
Anuj Shrestha
Wen-Jie Ma
Qin Yang
Jun-Ke Wang
Fei Liu
Nan-Sheng Cheng
Fu-Yu Li
Publikationsdatum
06.03.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3711-3

Weitere Artikel der Ausgabe 7/2018

Journal of Gastrointestinal Surgery 7/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.